According to Recent Research

About this episode

The episode features an interview with Dr. Stephanie Pisano discussing the FDA-approved dry eye treatment TRYPTYR and its potential impact on tear production.

🎧 Welcome to **Try Not 2 Blink!** Don’t miss a minute of today’s episode! 🚀 ✨ Here’s what’s coming up: **Fresh Drop!** 🚨 Discover **TRYPTYR** (pronounced trip-tear) — the FDA-approved dry eye treatment targeting cold-sensing receptors in your cornea and eyelid. Not minty eyedrops, but a potential game-changer for boosting tear production! 💧💥 **Exclusive Interview!** 🎙️ Sit down with **Dr. Stephanie Pisano**, Associate Professor of Ophthalmology & Vision Science at The Ohi...

People in this episode

Host: Valley Contax

Guest: Dr. Stephanie Pisano

Topics covered

• dry eye treatment
• ophthalmology
• tear production
• healthcare innovation
• interview

Keywords

• dry eye
• FDA-approved
• ophthalmology
• tear production
• healthcare

Mentioned in this episode

Organizations: The Ohio State University

Products: TRYPTYR

More episodes of Blink Collective

• Blink Collective - Episode 4 · May 26, 2026 · 52 min
• Blink Collective - Episode 3 · April 24, 2026 · 59 min
• Blink Collective - Episode 2 · March 26, 2026 · 45 min
• Blink Collective - Episode 1 · February 26, 2026 · 36 min
• Magicians, Mathematicians or Scleral Clinicians? · July 14, 2025 · 58 min
• Be the Beam of Light · July 7, 2025 · 57 min